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Cells respond to stress and starvation by adjusting
their growth rate and enacting stress defense pro-
grams. In eukaryotes this involves inactivation of
TORC1, which in turn triggers downregulation of
ribosome and protein synthesis genes and upregula-
tion of stress response genes. Here we report that
the highly conserved inositol pyrophosphate (PP-
IP) second messengers (including 1-PP-IP5, 5-PP-
IP4, and 5-PP-IP5) are also critical regulators of cell
growth and the general stress response, acting in
parallel with the TORC1 pathway to control the activ-
ity of the class I histone deacetylase Rpd3L. In fact,
yeast cells that cannot synthesize any of the PP-IPs
mount little to no transcriptional response to
osmotic, heat, or oxidative stress. Furthermore,
PP-IP-dependent regulation of Rpd3L occurs inde-
pendently of the role individual PP-IPs (such as
5-PP-IP5) play in activating specialized stress/
starvation response pathways. Thus, the PP-IP sec-
ond messengers simultaneously activate and tune
the global response to stress and starvation signals.
INTRODUCTION
To thrive when conditions are favorable and survive when they
are stressful, cells must set their growth rate based on the level
and combination of numerous intracellular and extracellular
stimuli (Schmelzle and Hall, 2000). How this is accomplished
remains unclear.
What is known is that in eukaryotes, cell growth depends to a
large degree on a single kinase called TOR (Laplante and
Sabatini, 2012; Loewith and Hall, 2011). When conditions are
favorable, TOR drives mass accumulation by promoting all
aspects of protein and ribosome synthesis. Conversely, in stress
conditions or when hormone or nutrient levels fall outside of an
ideal range, TOR activity is repressed. This triggers inhibition of
protein synthesis and activation of numerous stress and starva-
tion response pathways.
Studies in the budding yeast S. cerevisiae have begun to
reveal the precise mechanisms underlying TOR-dependent1476 Cell Reports 3, 1476–1482, May 30, 2013 ª2013 The Authorsregulation of growth. In particular, it is now clear that TOR is
part of a multisubunit complex called TORC1 (Loewith et al.,
2002), and that this complex signals through two distinct chan-
nels to regulate a global gene-expression program known as
the environmental stress response (ESR) (Airoldi et al., 2009;
Brauer et al., 2008; Gasch et al., 2000; Loewith et al., 2002).
In one channel, active TORC1 promotes the expression of 650
genes involved in ribosome and protein synthesis by regulating
the activity of the S6 kinase Sch9 and numerous transcription
factors, including Sfp1, Fhl1, Maf1, Dot6, and Tod6 (Huber
et al., 2011; Lempia¨inen et al., 2009; Lippman and Broach,
2009; Marion et al., 2004; Martin et al., 2004). When TORC1 is
inactivated, dephosphorylation of the TORC1- and Sch9-depen-
dent transcription factors triggers recruitment of the class I
histone deacetylase (HDAC) Rpd3L to ribosome and protein
synthesis genes, leading to their repression (Alejandro-Osorio
et al., 2009; Huber et al., 2011).
In the other channel, active TORC1 blocks the expression of
600 stress and starvation response genes by binding and
sequestering a key regulator of the PP2A phosphatases,
Tap42 (Alejandro-Osorio et al., 2009; Huber et al., 2011). In
stress and starvation conditions, Tap42 is released from
TORC1 and activates PP2A (Yan et al., 2012; Yan et al., 2006).
This in turn triggers the dephosphorylation and activation of
transcription factors that promote amino acid synthesis, nitrogen
metabolism, the tricarboxylic acid (TCA) cycle, and the general
stress response, including Gln3, Gat1, Rtg1/3, and Msn2/4
(Beck and Hall, 1999; Huber et al., 2009). Together, the PP2A-
dependent transcription factors function by converting the
HDAC Rpd3L from a repressor to an activator at the stress/
starvation response genes (Alejandro-Osorio et al., 2009).
What remains to be determined, in bothS. cerevisiae and other
organisms, is howstress and starvation signals are transmitted to
TORC1 and which pathways (if any) cooperate with TORC1 to
regulate growth and metabolism. Answering these questions is
a prerequisite to building a realistic model of the cellular growth
control circuitry, andultimately tounderstandinghowcellsdecide
how fast to grow in different environments, how they keep growth
and metabolism balanced, and how malfunction of the growth
control system leads to diseases such as cancer and diabetes
(Laplante and Sabatini, 2012; Loewith and Hall, 2011).
Here, to gain insight into the structure and function of the
eukaryotic growth control network, we use DNA microarray
analysis to examine the influence that 17signalingproteinsknown
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Figure 1. PP-IP Synthesis Pathway
Biochemical studies have uncovered themajor steps in inositol phosphate and
pyrophosphate synthesis (Shears, 2009). In brief, the lipid PIP2 is cleaved by
Plc1, releasing IP3 into the cytoplasm. IP3 is then converted into IP4 and IP5 by
Arg82, while IP5 is converted into IP6 by Ipk1. Finally, Kcs1 phosphorylates IP5
and IP6 at the 5 position, and Vip1 phosphorylates IP6 at the 1 position, to
create the inositol pyrophosphates 1-PP-IP5, 5-PP-IP4, and 5-PP-IP5. See text
for further details and references.to be (de)phosphorylated during stress inS. cerevisiae (Figure S1;
Soufi et al., 2009) have on the ESR. Surprisingly, our data reveal
that only one of these factors, the inositol kinase Vip1, plays a
significant role in regulating the ESR and thus cell growth.
Previous studies have shown that Vip1 is part of the inositol
pyrophosphate (PP-IP) synthesis pathway, which is conserved
throughout eukaryotes (Figure 1). In the first step of this pathway,
phosphatidylinositol 2-phosphate (PIP2) is cleaved by phospho-
lipase C (Plc1) to release the lipid diacylglycerol and the soluble
inositol head group IP3 (Shears, 2009). IP3 itself is a signaling
molecule with a well-established role in calcium signaling (Ber-
ridge et al., 2000; Streb et al., 1983). More recently, however, it
has been shown that IP3 can be converted to IP4 and IP5 in the
nucleus by the inositol polyphosphate multikinase Arg82, and
then to IP6 by the inositol polyphosphate kinase Ipk1 (Burton
et al., 2009; Chakraborty et al., 2011; Shears, 2009; Tsui and
York, 2010). IP5 and IP6 can also be pyrophosphorylated by
Kcs1 to create a diphosphate at the 5-position (5-PP-IP4/5),
and IP6 can be pyrophosphorylated by Vip1 to create a diphos-
phate at the 1-position (1-PP-IP5) (Fridy et al., 2007; Mulugu
et al., 2007; Shears, 2009). The diphosphorylated inositols
synthesized by Vip1 and Kcs1 are known as the PP-IPs.
The identification of Vip1 as an important regulator of the ESR
led us to investigate the role that PP-IPs play in regulating cellCgrowth. To do this, we measured the influence that each enzyme
in the PP-IP synthesis pathway (Arg82, Ipk1, Vip1, and Kcs1) has
on gene expression, in both log-growth and stress conditions.
Through this analysis we discovered that the three major PP-IPs
cooperate to activate the ESR. In fact, a strain that is unable to
synthesize any PP-IP (kcs1Dvip1D) mounts little to no transcrip-
tional response to heat, osmotic, or oxidative stress.
To determine how the PP-IPs regulate the ESR and cell
growth, we also measured signaling at each stage of the
TORC1 pathway in kcs1Dvip1D and wild-type (WT) strains.
These experiments revealed that the PP-IPs act in parallel with
the canonical TORC1 signaling pathway to activate the HDAC
Rpd3L. PP-IP activation of Rpd3L may be direct, because we
found that mutation of residues in an inositol-binding site on
the surface of Rpd3, identified when a crystal structure of human
HDAC3-SMART complexwas found to contain IP4, has the same
general effect on cell signaling as does blocking the production
of the PP-IPs themselves.
Taken together, our data show that the PP-IPs are critical
regulators of the ESR and cell growth, with an overall impact
similar to that of TORC1 itself. Moreover, our discovery that
the PP-IPs activate the HDAC Rpd3L reveals a core function of
these conserved second messengers in cell signaling. These re-
sults have important implications for our understanding of cell-
growth control in eukaryotes as well as the regulation of HDAC
activity in health and disease.
RESULTS
Vip1 Regulates the ESR
To identify proteins that regulate the ESR and thus cell growth,
we performed a directed screen. In the first step, we searched
a recently published phosphoproteomics data set (Soufi et al.,
2009) to find proteins that are rapidly (in <5 min) phosphorylated
or dephosphorylated in osmotic stress (at p < 0.05; Figure S1).
Through this analysis, we generated a list of 24 signaling proteins
that are likely to regulate the ESR but have not previously been
studied in detail (see Extended Results for details). We then
created a series of strains, eachmissing one of the 17 nonessen-
tial genes on our list, and measured their response to osmotic
stress using DNAmicroarrays. These data revealed that deletion
of Vip1, an evolutionarily conserved PP-IP synthase, inhibits the
ESR (238 genesR 1.5-fold change; Figure S2).
PP-IPs Act Redundantly to Regulate the ESR
Our discovery that Vip1 regulates the ESR led us to study the role
that inositol phosphates and pyrophosphates play in stress
signaling.
First, we asked whether Vip1 influences the ESR through
1-PP-IP5 by measuring gene expression in a strain carrying a
catalytically dead Vip1 mutant (D487A; Mulugu et al., 2007).
We found that vip1D487A and vip1D strains have similar ex-
pression patterns—both with defects in their stress response
(Figure S3; Table S1). Thus, 1-PP-IP5 and/or other PP-IPs syn-
thesized by Vip1 are required for activation of the ESR.
Next, we asked whether any inositol phosphates other than
1-PP-IP5 influence the ESR. To do this, we measured the impact
that each enzyme in the PP-IP synthesis pathway (Figure 1) hasell Reports 3, 1476–1482, May 30, 2013 ª2013 The Authors 1477
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Figure 2. Role of the Inositol Phosphates
and Pyrophosphates in Gene Regulation
(A) DNAmicroarray data showing gene expression
in log growth (YEPD, OD600 = 0.6) or in response to
osmotic stress (0.4 M KCl, 20 min) in strains
missing one or more of the enzymes in the
inositol polyphosphate/pyrophosphate (IP) syn-
thesis pathway. Each experiment compares the
mRNA levels in a mutant strain with those in the
WT strain, in identical conditions. In all of these
experiments, cDNA from mutant strains was
labeled with Cy5 and that from the WT strain was
labeled with Cy3. Thus, genes that are upregulated
in the mutant strains appear red, and genes that
are downregulated are green. The WT stress
response (osmotic stress sample labeled red, log
growth labeled green) is shown at far left for
comparison. The heatmap shows data for all of the
genes in the ESR based on the average of two to
three replicate experiments per microarray (Table
S1). Other genes regulated by the inositol phos-
phate pathway are described in the Extended
Results and Figure S4. Within the ESR, the corre-
lation between the expression changes found in
the kcs1Dvip1D strain and the arg82D strain is very
strong, with a Pearson’s r of 0.70 in YEPD, 0.77 for
genes repressed in stress, and 0.63 for genes
activated in stress. The correlation between the
expression changes found in the kcs1Dvip1D and
ipk1D strains is also strong for genes repressed in
stress (r = 0.69), but moderate in YEPD (r = 0.45)
and for genes activated in stress (r = 0.49). Lastly,
the expression changes found in the kcs1D and
vip1D strains also correlatewell with those found in
the arg82D strain (r = 0.76–0.52 for the three gene
groups listed above) except that there is little to no
correlation between the influence of Vip1 and
Arg82 in YEPD (r = 0.12), suggesting that Vip1 is
less important than Kcs1 for PP-IP synthesis in YEPD growth conditions. Overall, the strong correlation between the expression changes caused by deleting Kcs1
and Vip1 and removing their key substrates (IP5 and IP6) via deletion of Arg82 or Ipk1 indicates that it is the PP-IPs, and not other (unknown) molecules
synthesized by Kcs1/Vip1, that regulate the ESR.
(B) Bar graph showing the defect in ribosome biogenesis (Ribi) gene repression for each mutant strain and condition in (A). Note that arg82D cells still produce
some PP-IPs since Kcs1 phosphorylates and pyrophosphorylates IP3 to create PP-IP3, PP-IP4, and other PP-IP species when IP5 and IP6 are not available as
substrates (Seeds et al., 2005). Accordingly, the expected concentration of PP-IPs in kcs1Dvip1D < arg82D < kcs1D and ipk1D < vip1D (Figure 1; Seeds et al.,
2005).on gene expression, in both log-growth and osmotic-stress
conditions. Remarkably, these data show that 1,647 genes are
activated/repressed (R2-fold) by Arg82, Ipk1, Kcs1, and/or
Vip1. Most of these genes (1,272/1,647) are part of the ESR (Fig-
ures 2A and S4), in line with our results for the vip1D and
vip1D487A strains. The remaining genes are primarily known
targets of the PP-IPs, including the phosphate-signaling
pathway, a target of 1-PP-IP5 via Pho80/85 (Lee et al., 2007,
2008), and the glycolysis pathway, a target of 5-PP-IP4/5 via
Gcr1 (Szijgyarto et al., 2011), as described in detail in Figure S4.
The expression data for genes within the ESR are especially
illuminating. First, the data show that deletion of the two PP-IP
synthases in yeast, Kcs1 and Vip1, has a much bigger effect
on the transcriptional response to stress than deletion of Vip1
alone (Figure 2A). Specifically, the kcs1Dvip1D strain has a
dramatic defect in (1) the downregulation protein synthesis
genes in stress, (2) the repression of stress genes in log-growth
conditions, and (3) the activation of stress genes in stress condi-1478 Cell Reports 3, 1476–1482, May 30, 2013 ª2013 The Authorstions. Second, the data show that the enzymes upstreamof Kcs1
and Vip1 in the PP-IP synthesis pathway (Arg82 and Ipk1)
regulate nearly the same expression program as Kcs1 and
Vip1 (Figure 2A; see legend for Pearson’s r values). However,
the influence that each enzyme in the PP-IP synthesis pathway
has on the level of gene expression is roughly proportional to
the number of PP-IPs it helps to synthesize (Figures 2B and
S5). Taken together, these data indicate that the PP-IPs,
including 1-PP-IP5 and 5-PP-IP4/5, act partially redundantly to
regulate the ESR (see Extended Results for further discussion).
Finally, we asked whether the PP-IPs activate the ESR in
conditions other than osmotic stress. We found that kcs1Dvip1D
cells have similar dramatic defects in their response to osmotic,
oxidative, and heat stress (Figure 3). In fact, kcs1Dvip1D cells fail
to mount any significant response to H2O2 stress (Figure 3).
Thus, Kcs1, Vip1, and the PP-IPs are among the most potent
regulators of the ESR identified to date, with an influence similar
to that of TORC1 itself (Table S1).
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Figure 3. PP-IPs Regulate the ESR
(A and B) DNA microarray data showing the gene-expression programs acti-
vated in various stresses in WT and kcs1Dvip1D strains.
(A) Each column compares the mRNA levels in log-growth conditions (YEPD,
OD = 0.6) with the mRNA levels in the same strain after 20 min of the indicated
stress. In all of these experiments, cDNA from cells collected prior to stress
treatment were labeled with Cy3 (green) and cDNA from cells treated with
stress stimuli were labeled with Cy5 (red). Thus, genes activated by 0.4 M KCl,
42C heat shock, or 0.4 mM H2O2 are red on the heat map and genes
repressed in these stimuli are green. Only genes that are up- or downregulated
by >3-fold in one or more experiments are shown on the heat map. Clustering
these data revealed five gene groups, each of which is labeled by its major
gene ontology (GO) groups and the probability that aGOgroupwould be found
by chance. Microarrays are the average of at least two replicates.
(B) Each column shows the difference between the kcs1Dvip1D and WT
response to the stress indicated to highlight the Kcs1- and Vip1-regulated
genes.PP-IPs Regulate the ESR by Activating the HDAC Rpd3L
How then do the PP-IP second messengers regulate the ESR?
To answer this question, we first sought to determine whether
the PP-IPs act upstream or downstream of TORC1. We
reasoned that if the PP-IPs act upstream of TORC1, we should
be able to rescue the stress response in a strain missing the
PP-IPs (kcs1Dvip1D) by inhibiting TORC1 using the potent inhib-Citor rapamycin. Surprisingly, this was not the case. In fact,
rapamycin has almost no effect on signaling in kcs1Dvip1D cells
(Figure 4A), indicating that the PP-IPs act at or below the level
of TORC1.
To determine how the PP-IPs act downstream of TORC1, we
next examined signaling through the Sch9 channel. Previous
studies have shown that in log-growth conditions, TORC1 phos-
phorylates the S6 kinase Sch9, leading to its activation (Fig-
ure 4B; Urban et al., 2007). Active Sch9, in turn, phosphorylates
and inactivates the transcriptional repressors Dot6 and Tod6
(Lippman and Broach, 2009), both of which are part of the
HDAC complex Rpd3L (Huber et al., 2011; Shevchenko et al.,
2008). When TORC1 is inactivated by stress, Sch9, Dot6, and
Tod6 are all rapidly dephosphorylated and the protein synthesis
genes are repressed by active Dot6/Tod6-Rpd3L (Huber et al.,
2009, 2011; Humphrey et al., 2004). Using band-shift analysis,
we monitored the stress-dependent phosphorylation of Dot6
and Tod6, and found that the switch from active TORC1 in
log-growth conditions to inactive TORC1 in stress conditions
occurs normally in the kcs1Dvip1D strain (Figure 4C). Therefore,
TORC1 is inactivated by stress, leading to dephosphorylation of
Dot6/Tod6 even in a strain missing all PP-IPs.
As inactivation of TORC1 and the subsequent dephosphoryla-
tion of transcription factors, including Dot6 and Tod6, ultimately
lead to activation of the ESR via the HDACRdp3L, we next asked
whether the PP-IPs regulate Rpd3L itself. To do this, we
measured the acetylation of three of the most PP-IP-dependent
protein synthesis genes (which were previously shown to be
deacetylated by Rpd3L during the ESR (Alejandro-Osorio
et al., 2009; Huber et al., 2011) both before and after osmotic
stress using a chromatin immunoprecipitation (ChIP) assay.
These experiments revealed a significant defect in stress-
dependent histone deacetylation in the kcs1Dvip1D strain at all
three genes (Figure 4D), indicating that Rpd3L does not function
appropriately in stress without the PP-IPs.
To test whether the PP-IPs influence the entire Rpd3-
mediated ESR, we next measured the ESR in a strain missing
the catalytic subunit in the Rpd3L complex (rpd3D) and com-
pared it with the data for the kcs1Dvip1D strain. We found that
the expression profiles for the rpd3D and kcs1Dvip1D strains
are remarkably similar, both in prestress conditions, where
Rpd3 acts to repress the expression of stress genes, and in
stress conditions, where Rpd3 switches to an activator of stress
genes and a repressor of ribosome and protein synthesis genes
(Figure 4E). We therefore conclude that the PP-IPs are required
for Rpd3L activity in both log-growth and stress conditions.
Do the PP-IPs Activate Rpd3L Directly?
After discovering that the PP-IPs activate Rpd3L in vivo, we
wanted to determine whether the PP-IPs function by binding
directly to the Rpd3L complex. While this work was in progress,
Watson et al. (2012) published a crystal structure of human
HDAC3 (Rpd3 in yeast) bound to the corepressor SMRT. The
structure revealed that the interaction between HDAC3 and
SMRT depends on an inositol 1,4,5,6-phosphate (IP4) molecule
located at the interface between the two proteins. Watson
et al. further showed that IP4 is required for activation of
HDAC3 by SMRT in vitro. Although it is unclear whether thereell Reports 3, 1476–1482, May 30, 2013 ª2013 The Authors 1479
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Figure 4. PP-IPs Regulate Rpd3L
(A) PP-IPs act at or below the level of TORC1. DNA
microarray data show genes up- or downregulated
>3-fold in response to 20 min of 0.4 M KCl in WT
(top) or in the kcs1Dvip1D strain (Cy3) compared
with the same strain treated with 0.4 M KCl and
300 nM rapamycin for 20 min (Cy5, bottom). The
gene-expression changes induced by rapamycin
in the WT strain are also shown for comparison
(middle). If the PP-IPs had acted upstream of
TORC1, treatment with rapamycin in stress would
have rescued the expression defect found in the
kcs1Dvip1D strain, leading to dramatic changes in
gene expression in rapamycin. Microarrays are the
average of three replicates.
(B) Known mechanism of stress-induced repres-
sion of Ribi genes. Inactivation of TORC1 leads to
Tod6/Dot6 activation and recruitment of the HDAC
Rpd3L to Ribi promoters, as described in the text.
(C) Stress signaling through the TORC1 pathway
still occurs in the absence of the PP-IPs. The
phosphorylation of Dot6-HA and Tod6-HA was
monitored by band-shift analysis both before and
after treatment with 0.4 M KCl. Here, cells were
treated with TCA and lysed, and whole-cell ex-
tracts were run on SDS-PAGE. Dot6 and Tod6
were identified using a western blot with an HA
antibody (12-CA5). The band shifts monitored here
were previously shown to be due to phosphoryla-
tion by Sch9 (Huber et al., 2009).
(D) PP-IPs are required for deacetylation at Ribi
genes in 0.4 M KCl stress. The acetylation level of
three highly regulated Ribi genes was measured in
the kcs1Dvip1D and WT strains, both before and
after KCl stress, using an antiacetylated-H4 anti-
body and quantitative PCR (qPCR). Plotted here is
the ratio of the prestress to poststress acetylation
level. No significant changes in the prestress
acetylation levels were found in the kcs1Dvip1D strain. However, stress triggers more deacetylation in the WT strain than in the kcs1Dvip1D strain; **p < 0.03,
*p < 0.1, t test values for null hypothesis. All graphs show the average and SD from three replicate experiments.
(E) Rpd3, the PP-IPs, and disruption of the inositol-phosphate-binding site on Rpd3L have similar effects on the ESR. The DNA microarrays show the change of
gene expression caused by deleting Rpd3, Kcs1 and Vip1, or mutating the inositol-binding site in Rpd3 (rpd3Dibs), in both log growth and 0.4 M KCl stress (after
20 min). In each case, cDNA from the mutant strain is labeled with Cy5, and cDNA from the WT strain (grown in identical conditions) is labeled with Cy3.
See also Figure S5.is a corepressor that acts like SMRT in yeast (see Extended
Results for discussion), these findings led us to ask whether
the PP-IPs activate Rpd3L by binding to the ‘‘IP4’’ site described
in the HDAC3-SMRT crystal structure. This seemed reasonable
given that (1) sequence alignment shows that the residues that
mediate the HDAC3-IP4 interaction are conserved across the
class I HDACs, including in Rpd3 (Watson et al., 2012), and (2)
examination of the HDAC3-SMRT structure (Protein Data Bank
ID code 4A69) shows that approximately half of the IP4 ring is
exposed to solvent, suggesting that the inositol-binding site on
Rpd3 could also accommodate 1-PP-IP5 or 5-PP-IP4/5.
To test whether the PP-IPs activate the Rpd3L complex by
binding to the inositol-phosphate-binding site on Rpd3, we
created a strainmissing the side chains of three solvent-exposed
residues that form salt bridges with IP4 in the HDAC3 structure
(Rpd3K41A,R280A,R316A, rpd3Dibs for short) and studied its
response to stress. We found that this rpd3Dibs strain has an
expression profile similar to those of the kcs1Dvip1D and
rpd3D strains, in both log-growth and stress conditions (Fig-1480 Cell Reports 3, 1476–1482, May 30, 2013 ª2013 The Authorsure 4E). Thus, activation of Rpd3L to WT levels requires both
the PP-IPs and an intact inositol-phosphate-binding site on
Rpd3. It therefore seems likely that the PP-IPs activate Rpd3L,
at least in part, by binding to same pocket that is occupied by
IP4 in the IP4-HDAC3 complex. However, further work is needed
to confirm that the PP-IPs bind and activate Rpd3L directly,
since the rpd3Dibs mutation could inhibit Rpd3L by disrupting
a PP-IP-independent function of Rpd3.
DISCUSSION
Over the last 5 years, the PP-IPs have emerged as important
signaling molecules in eukaryotic cells. First, it was discovered
that yeast synthesize 1-PP-IP5 in phosphate starvation condi-
tions and that this form of IP7 binds to Pho80/85, triggering
activation of phosphate-scavenging genes (Lee et al., 2007).
Later, 5-PP-IP5 was shown to play a role in human insulin
signaling, where it blocks activation of AKT by the lipid PIP3
(Chakraborty et al., 2010). Finally, a recent study in yeast
revealed that 5-PP-IP5 inhibits transcription of glycolysis genes
by regulating the transcription factor Gcr1 (Szijgyarto et al.,
2011). Here we show that these specific roles of 1-PP-IP5 and
5-PP-IP5 are just one aspect of PP-IP function. Significantly,
the PP-IPs also act together (partially redundantly) to regulate
a class I HDAC and thus the global gene-expression program.
In yeast, this means that 1-PP-IP5 activates both the phosphate
starvation pathway (15 genes) and the ESR (>1,200 genes), and
5-PP-IP4/5 downregulates glycolysis (50 genes) while activating
the ESR.
Beyond uncovering a core function of the PP-IPs, our study
provides important insight into the mechanisms underlying regu-
lation of the ESR and cell growth in yeast. A key conclusion from
our work here is that the PP-IPs act in parallel with the known
master regulator of growth in eukaryotes, TORC1, to control
Rpd3L. Furthermore, the influence that the PP-IPs have on
gene expression is similar in both scale and impact to that of
TORC1 itself (Figures 4A and 4E).
This raises the question, why would the cell use two parallel
signaling systems to control growth and the ESR, with
TORC1 targeting Rpd3L to the appropriate promoters and the
PP-IPs regulating Rpd3L activity? We favor two nonexclusive
possibilities. First, this AND gate may filter noise in the TORC1
and PP-IP synthesis pathways, preventing unintentional and
transient reprogramming of one-fifth of the genome. Second,
PP-IP signaling may tune or control the dynamics of the
response to TORC1 inhibition. The latter point may be especially
important, because total Rpd3L activity increases dramatically in
stress conditions (Figure 4E).
Distinguishing between these and other models of PP-IP and
TORC1 cooperation will require a more detailed view of the
way PP-IP synthesis is regulated. Currently, no upstream regula-
tors of Kcs1 or Vip1 have been identified in yeast, and it is only
possible to measure the bulk level of inositol phosphates and
pyrophosphates in the cell (Shears, 2009). These bulk measure-
ments are unlikely to provide a realistic view of PP-IP production
because synthesis may occur at specific locations within the cell
and the PP-IPs are known to turn over rapidly (Menniti et al.,
1993). It is clear, however, that PP-IP levels increase in some
stress and starvation conditions (Lee et al., 2007; Nagata et al.,
2005; Pesesse et al., 2004), in line with a model in which PP-IP
levels increase in stress to upregulate Rpd3L activity.
The results presented here also have important implications
for cancer research. Studies in human cells have shown that
IP6K2, a human homolog of Kcs1, is required for efficient in-
duction of apoptosis in stress conditions and is missing in
some squamous cell carcinomas (Morrison et al., 2001, 2009;
Nagata et al., 2005). Cells missing the PP-IPs fail to activate
apoptosis in stress because they erroneously upregulate cell-
cycle-arrest genes when they should only activate proapoptotic
genes (Koldobskiy et al., 2010). In other words, the cells arrest
before they can apoptose. Our discovery that the PP-IPs are
required for HDAC activation sheds light on why this happens,
because it is known that HDAC1 (another homolog of Rpd3L)
must cooperate with p53 to downregulate the cell-cycle-arrest
genes in stress (Lagger et al., 2003; Ocker and Schneider-
Stock, 2007). This suggests that small molecules that mimic
PP-IP4/5 and activate HDAC1 may help push cancer cellsCaway from arrest and toward apoptosis in stresses such as
chemotherapy.
EXPERIMENTAL PROCEDURES
Yeast cells were grown fromOD600 = 0.10 to 0.60 in YEPDmedium at 30
C and
then harvested for further analysis (log-growth samples) or treated with stress
(0.4 M KCl, 42C final temperature or 0.4 mM H2O2) and harvested after 5 or
10 min to examine signaling/histone acetylation, or after 20 min to examine
messenger RNA (mRNA) levels. For microarrays, mRNA was extracted from
the cells using hot phenol, purified using a poly A sepharose column, and
converted to aa-UTP-labeled complementary DNA (cDNA) using StrataScript
reverse transcriptase. The cDNA was then labeled with Cy3 or Cy5, and
transcript levels measured using Agilent G4813A DNA microarrays and an
Axon 4000B scanner. For band-shift experiments, TCA-treated cells were
lysed by bead-beating in urea buffer, the cell extracts were run on an SDS-
PAGE gel, and Dot6 and Tod6 mobility was measured using western blotting
and the Li-Cor infrared imaging system. ChIP samples were purified using
standard procedures and the enrichment levels were measured using real-
time PCR. A more detailed description of the materials and methods used in
this work, including all buffers and reagents, is provided in the Extended
Experimental Procedures. The strains and primers used in this study are listed
in Tables S2 and S3, respectively.
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